Member Posts > Cardiol Therapeutics: Building Strategic Partnerships for Global Impact
To expand its global footprint, Cardiol Therapeutics (NASDAQ: CRDL; TSX: CRDL) is actively pursuing strategic alliances and licensing agreements. Through key investor and biotech conferences, the company is fostering business collaborations to accelerate market entry.
Upcoming Strategic Partnership Events
📅 TD Cowen 45th Annual Health Care Conference (March 3-5, 2025)
• Evaluating joint ventures and co-development opportunities.
📅 37th Annual ROTH Conference (March 16-18, 2025)
• Discussions with potential global pharmaceutical partners.
Recent Business Development Highlights
📊 Oppenheimer Healthcare Conference (Feb 11-12, 2025)
• Explored licensing and M&A strategies.
📢 Follow Cardiol's partnership journey:

#Biotech #Investing #StockMarket #CardiolTherapeutics #NASDAQ #Healthcare #Pharma #Finance #MarketNews #HeartHealth #MedicalInnovation #Myocarditis #Pericarditis #HealthcareResearch #CannabidiolResearch #CardiolRx #LifeSciences #BiotechConference #InvestorUpdates